UNSPSC 51262413: Reproterol hydrochloride

This classification denotes a metaproterenol analog C18H23N5O5.ClH, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier Y4I1COJ8W8, chemically known as 1h-purine-2,6-dione, 7-(3-((2-(3,5-dihydroxyphenyl)-2-hydroxyethyl)amino)propyl)-3,7-dihydro-1,3-dimethyl-, monohydrochloride, but more generally known as reproterol hydrochloride, which bears US NIH Compound Identifier 3032600. European Medicines Agency schedules Reproterol hydrochloride in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB04218MIG.

Most nations, for tariff and trade purposes, schedule reproterol hydrochloride under HS 29395900 and SITC 54145. As of Q4 2014, REPROTEROL HYDROCHLORIDE remains US FDA's Preferred Term for this commodity. SMILES: CN1C2C(C(=O)N(C1=O)C)N(CN2)CCCNCC(C3CC(CC(C3)O)O)O.CL.

UNSPSC 51262413 Reproterol hydrochloride is a Commodity code that nominally designates a specific pharmaceutical active ingredient, but recent state and local procurement activity under this code shows a significant mismatch. The single recent opportunity posted under the code — Seminole County, Florida's IFB60459723LAS — is not procuring reproterol hydrochloride at all, but rather naloxone and safe drug deactivation systems. The county is seeking 1,900 units of naloxone and 800 safe drug deactivation systems annually for delivery to the Seminole County Community Health Building. This divergence between the code's nominal scope and the work actually being bought indicates either a data-classification error or a use of the code outside its intended pharmaceutical category.

The Seminole County opportunity, posted June 30, 2026, with responses due July 26, 2026, is structured as a competitive IFB with quarterly deliveries, a two-year initial term plus one-year renewal option, and fixed pricing. Vendors must include all shipping and delivery costs in their bids, meet E-Verify and drug-free workplace compliance, and carry workers' compensation, commercial general liability, and professional liability insurance. The contract includes a three-month probationary termination clause and is potentially FEMA-funded, triggering federal environmental compliance requirements. Based on available records, no other recent state and local opportunities appear under this code, suggesting minimal current procurement activity for reproterol hydrochloride itself within state and local government. Firms should verify the correct code classification for pharmaceutical procurement targets before pursuing opportunities or flagging this code as low-priority for reproterol hydrochloride business development.